MedPath

Early infant male circumcision using devices

Not Applicable
Conditions
HIV/AIDS
Surgery
Urological and Genital Diseases
Paediatrics
Early infant circumcision ultimately for HIV prevention
Registration Number
PACTR201301000465398
Lead Sponsor
Bill and Melinda Gates Foundation
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Male
Target Recruitment
150
Inclusion Criteria

Live born male infants at study sites aged 7-10 days.
Ability to follow-up regularly at study clinic until 2 weeks postpartum
Mother prepared to provide locator information and to be visited home between delivery and circumcision
Mother prepared to provide verifiable cell phone (mobile) number
Provision of written informed consent
Baby should have received vitamin K (routine or offered by study staff)

Exclusion Criteria

Neonatal sepsis or other severe illness requiring infant hospitalization
Penile abnormality that might require reconstructive surgery in the future
Family history of bleeding disorder
Estimated infant gestational age < 36 weeks (we envisage that this information would be sufficiently and accurately recorded on the child health card by clinic staff)
Infant delivery weight < 2,500 grams (we envisage that this information would be sufficiently and accurately recorded on the child health card by clinic staff)
Infant >10 days of age
Infant receipt of methaemoglobin-inducing agents
Current involuntary incarceration of mother

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath